Cesarean Delivery Clinical Trial
Official title:
Undesired Effects of Carbetocin Compared To Oxytocin Administered As Single Intravenous Dose or Infusion During Cesarean Delivery: A Prospective Randomised Controlled Study
As both oxytocin and carbetocin are used daily in obstetric units all over the world, the investigators find it compelling to investigate whether the hemodynamic and myocardial effects of oxytocin and carbetocin are comparable in healthy women during delivery and determine any potential harmful effects following the use of oxytocin or Carbetocin as uterotonic. Other endpoints relating to uterus tone, blood loss, blood pressure, heart rate, post-operative pain and side effects will also be assessed.
Although the difference between carbetocin and oxytocin in terms of hemodynamic changes, postpartum blood loss and incidence of side effects is not statistically significant. serious cardiovascular adverse events, including ST segment depression, hypotension and tachycardia have been reported after IV oxytocin. Oxytocin dose reduction and/or increased infusion duration may reduce risk of some cardiac-related adverse effects and increase patient safety. As both oxytocin and carbetocin are used daily in obstetric units all over the world, the investigators find it compelling to investigate whether the hemodynamic and myocardial effects of oxytocin and carbetocin are comparable in healthy women during delivery and determine any potential harmful effects following the use of oxytocin or Carbetocin as uterotonic. Other endpoints relating to uterus tone, blood loss, blood pressure, heart rate, post-operative pain and side effects will also be assessed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03236324 -
Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery
|
Phase 2 | |
| Recruiting |
NCT04058444 -
The First ERAS Protocol for Cesarean Delivery in Serbia at the University Hospital
|
N/A | |
| Completed |
NCT03150641 -
Delayed Cord Clamping at Term Cesarean
|
N/A | |
| Recruiting |
NCT06247852 -
Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
|
||
| Completed |
NCT02846129 -
Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery
|
N/A | |
| Completed |
NCT00799955 -
Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block
|
N/A | |
| Completed |
NCT03336541 -
Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
|
Phase 4 | |
| Completed |
NCT04358757 -
Immune and Physical Recovery Following Cesarean Delivery
|
||
| Completed |
NCT01755026 -
Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery
|
Phase 4 | |
| Recruiting |
NCT03746678 -
Patient-Centred Perioperative Mobile Application
|
||
| Completed |
NCT03349151 -
Postoperative Results of Early Versus On-demand Maternal Feeding After Cesarean Delivery
|
N/A | |
| Completed |
NCT03729076 -
Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia
|
N/A | |
| Completed |
NCT04799587 -
Accupressure of P6 to Reduce Nausea During Cesarean Section
|
N/A | |
| Completed |
NCT03781388 -
ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
|
Phase 4 | |
| Completed |
NCT04349215 -
Validation of the Chinese ObsQoR-11
|
||
| Completed |
NCT04812223 -
Timing of Umbilical Cord Clamping in Term Cesarean Deliveries
|
N/A | |
| Recruiting |
NCT05279703 -
Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery
|
Phase 4 | |
| Completed |
NCT01550640 -
Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
|
N/A | |
| Completed |
NCT00884026 -
Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia?
|
N/A | |
| Completed |
NCT03830307 -
NSS-Bridge Device for Post-Cesarean Delivery Pain
|
N/A |